Meyka Pro banner
Arvinas, Inc.

Arvinas, Inc. (ARVN) Stock Overview

Explore Arvinas, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ARVNNASDAQ
HealthcareBiotechnology
$8.46
$0.40(5.02%)
U.S. Market is Open · 13:31

Arvinas, Inc. (ARVN)

Meyka AI Score

Z

Key Financials

Market Cap580.7M
P/E Ratio40.43
EPS (TTM)$-3.32
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$8.70
3 Months$13.52
1 Year Target$10.31

ARVN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Arvinas, Inc. (NASDAQ: ARVN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Arvinas, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ARVN on the NASDAQ shows an RSI of 65.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.31 for the NASDAQ listing.

Key metrics behind Arvinas, Inc.'s NASDAQ-traded stock include a P/E ratio of 40.43 and a market capitalization of 580.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ARVN on the NASDAQ.

Price Performance (NASDAQ: ARVN)

1-Day Change
11.66%
5-Day Change
10.97%
1-Month Change
6.51%
3-Month Change
-16.51%
6-Month Change
-32.79%
Year-to-Date (YTD) Change
-24.11%
1-Year Change
19.52%
3-Year Change
-62.53%
5-Year Change
-90.93%
All-Time (Max) Change
-43.93%

Contact Information

203 535 1456
5 Science Park, New Haven, CT, 06511

Company Facts

2,460 Employees
IPO DateSep 27, 2018
CountryUS
Actively Trading

Frequently Asked Questions